Back
Sarepta Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
128.96
Seasonality Move:
11.13%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.- The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.53 | Buy |
| 20-day SMA: | 124.83 | Buy |
| 50-day SMA: | 128.74 | Buy |
| 200-day SMA: | 130.35 | Sell |
| 8-day EMA: | 129.2 | Buy |
| 20-day EMA: | 127.16 | Buy |
| 50-day EMA: | 128.69 | Buy |
| 200-day EMA: | 127.96 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 58.34 | Buy |
| Chaikin Money Flow: | -9031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.84 - 128.84) | Buy |
| Bollinger Bands (100): | (123 - 147.2) | Sell |
Sarepta Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 130.19 while SRPT 8-day simple moving average is 129.53, which is a Buy signal.
- The stock price of SRPT is 130.19 while Sarepta Therapeutics 20-day SMA is 124.83, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 128.74 while SRPT share price is 130.19, making it a Buy technically.
- SRPT stock price is 130.19 and Sarepta Therapeutics 200-day simple moving average is 130.35, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
12.42B
Price in USD:
130.19
Share Volume:
344.28K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
55.25
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 130.19 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 130.19 while SRPT 8-day exponential moving average is 129.20, which is a Buy signal.
- The stock price of SRPT is 130.19 while Sarepta Therapeutics 20-day EMA is 127.16, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 128.69 while SRPT share price is 130.19, making it a Buy technically.
- SRPT stock price is 130.19 and Sarepta Therapeutics 200-day simple moving average is 127.96, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is 1.05, suggesting Sarepta Therapeutics is a Buy
- Sarepta Therapeutics Relative Strength Index (RSI) is 58.34, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (120.84 - 128.84), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (123 - 147.2), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.